26.20MMarket Cap-0.06P/E (TTM)
9.018High8.470Low206.97KVolume8.620Open8.670Pre Close1.81MTurnover9.06%Turnover RatioLossP/E (Static)3.03MShares27.50052wk High-12.89P/B19.78MFloat Cap4.06052wk Low--Dividend TTM2.28MShs Float1751062.500Historical High--Div YieldTTM6.33%Amplitude4.060Historical Low8.729Avg Price1Lot Size
Traws Pharma Stock Forum
📊⚡️📊
Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval
Monday, 30th December at 8:00 am
Initial tranche of $20 Million extends cash runway into 1H26, subsequent tranche of up to $52.6 Million will provide for runway 3+ years enabling the company to reach both near-term and long-term value inflecting readouts
NEWTOWN, Pa., Dec. 30, 2024 /PRNewswir...
$Apple (AAPL.US)$
$Traws Pharma (TRAW.US)$
DO NOT WORRY, THIS IS SOMETHING THAT I CAN AFFORD. DO NOT TRY SOMETHING LIKE THIS UNLESS YOU CAN AFFORD IT. DO NOT RISK TOO MUCH AND USE STRATEGIES.
📊⚡️📊
No comment yet